applsci-logo

Journal Browser

Journal Browser

Design, Synthesis, Analysis and Application of Antiviral Agents

A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Chemical and Molecular Sciences".

Deadline for manuscript submissions: 20 April 2026

Special Issue Editors


E-Mail Website
Guest Editor
Laboratorio de Medicina de Conservación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Col. Casco de Santo Tomás, Mexico City 11340, Mexico
Interests: virology; antiviral; vaccines

E-Mail Website
Guest Editor
Laboratory for the Design and Development of New Drugs and Biotechnological Innovation, Escuela Superior de Medicina, Instituto Politécnico Nacional, México City 11340, Mexico
Interests: computational antiviral design

E-Mail Website
Guest Editor
Laboratorio de Neurofisiología, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Mexico City 11340, Mexico
Interests: GPCR; adrenergic; molecular modelling; drug design; boron-containing compounds
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It has been over sixty years since the U.S. Food and Drug Administration (FDA) approved the first antiviral, idoxuridine, an iodinated analogue of the nucleosides deoxyuridine and thymidine. Since then, antiviral development has expanded considerably, with modern candidates required to demonstrate specific activity against viral targets by inhibiting essential steps in the replication cycle, such as viral entry, genome replication, protein synthesis or processing, assembly, and egress. Beyond pharmacological properties such as bioavailability, tissue penetration, and low or no toxicity, these features differentiate antivirals from molecules with virucidal or immunomodulatory activity.

The continuous emergence of new viruses, the reappearance of previously controlled pathogens, and the wide clinical spectrum of viral diseases—from mild infections like the common cold to high-mortality outbreaks such as Ebola, chronic diseases like HIV/AIDS, and global pandemics such as influenza and SARS-CoV-2—underscore the urgent need for novel antiviral strategies. Effective drug design, synthesis, and evaluation of molecules with potential antiviral activity is important. Effective drug design must account for viral proteins, host factors, pathogen—host interactions, immune responses, mechanisms of immune evasion, and disease pathogenesis.

In this Special Issue, we address the development of antivirals from the design to the application, explaining their potential mechanisms of action.

Dr. Jazmín García-Machorro
Dr. Marlet Martinez-Archundia
Dr. Marvin Antonio Soriano-Ursúa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antivirals
  • in silico
  • in vitro
  • in vivo
  • target
  • replication cycle
  • viral protein
  • viral entry
  • viral assembly and exit

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop